Triflora Gel
NDC Package 68466-2001-4
Package Information
Triflora Gel (urtica dioica, toxicodendron pubescens leaf, ledum palustre twig) gel is temporarily relieves minor aches, pains, and joint/muscle stiffness associated with arthritis, rheumatism, simple backache and tendinitis. This formulation utilizes a gel delivery system. Marketed by Schwabe Mexico S.a. De C.v., this product is identified by NDC 68466-2001.
Identification & Billing
Clinical Specifications
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Regulatory & Marketing
Hierarchy Structure
- 68466 - Schwabe Mexico S.a. De C.v.
- 68466-2001 - Triflora Gel
- 68466-2001-4 - 1 TUBE in 1 CARTON / 28 g in 1 TUBE
- 68466-2001 - Triflora Gel
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68466-2001). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68466-2001-4 identifies a specific commercial package of 1 tube in 1 carton / 28 g in 1 tube of Triflora Gel, a human over the counter drug labeled by Schwabe Mexico S.a. De C.v.. This gel is formulated for topical; topical use and contains ledum palustre twig; toxicodendron pubescens leaf; urtica dioica as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Schwabe Mexico S.a. De C.v. on October 01, 2021. The current certification is valid through December 31, 2026.
How is this Schwabe Mexico S.a. De C.v. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68466200104. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.